» Articles » PMID: 33148439

Cognitive Disorders Associated with Hospitalization of COVID-19: Results from an Observational Cohort Study

Overview
Publisher Elsevier
Date 2020 Nov 5
PMID 33148439
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Our understanding of risk factors for COVID‑19, including pre-existing medical conditions and genetic variations, is limited. To what extent the pre-existing clinical condition and genetic background have implications for COVID-19 still needs to be explored.

Methods: Our study included 389,620 participants of European descent from the UK Biobank, of whom 3,884 received the COVID-19 test and 1,091 were tested positive for COVID-19. We examined the association of COVID-19 status with an extensive list of 974 medical conditions and 30 blood biomarkers. Additionally, we tested the association of genetic variants in two key genes related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2), with COVID-19 or any other phenotypes.

Results: The most significant risk factors for COVID-19 include Alzheimer's disease (OR = 2.29, 95% CI: 1.25-4.16), dementia (OR = 2.16, 95% CI: 1.36-3.42), and the overall category of delirium, dementia, amnestic and other cognitive disorders (OR = 1.90, 95% CI: 1.24-2.90). Evidence suggesting associations of genetic variants in SARS-CoV-2 infection-related genes with COVID-19 (rs7282236, OR = 1.33, 95% CI: 1.14-1.54, p = 2.31 × 10) and other phenotypes, such as an immune deficiency (p = 5.65 × 10) and prostate cancer (p = 1.1 × 10), was obtained.

Conclusions: Our unbiased and extensive search identified pre-existing Alzheimer's disease and dementia as top risk factors for hospital admission due to COVID-19, highlighting the importance of providing special protective care for patients with cognitive disorders during this pandemic. We also obtained evidence suggesting a direct association of genetic variants with COVID-19.

Citing Articles

Investigation of the effect of green walking and intelligence games on the cognitive skills of individuals between the ages of 50-70 survived COVID-19 disease: A randomized controlled study.

Akeren Z, Hintistan S J Alzheimers Dis Rep. 2025; 8(1):1394-1404.

PMID: 40034357 PMC: 11863725. DOI: 10.1177/25424823241284500.


Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis.

Shan D, Wang C, Crawford T, Holland C BMC Geriatr. 2024; 24(1):940.

PMID: 39674870 PMC: 11646349. DOI: 10.1186/s12877-024-05538-5.


COVID-19 Hospitalization Outcomes for Long-Term Care Facility Residents With Dementia: Mediation by Pre-existing Health Conditions.

Yin C, Mpofu E, Brock K, Ingman S Gerontol Geriatr Med. 2024; 10:23337214241284035.

PMID: 39323570 PMC: 11423368. DOI: 10.1177/23337214241284035.


Associations between cohort derived dementia and COVID-19 serological diagnosis among older Black adults in rural South Africa.

Harriman N, Bassil D, Farrell M, Du Toit J, Gomez-Olive Casas F, Tollman S Front Public Health. 2024; 11:1304572.

PMID: 38249406 PMC: 10796535. DOI: 10.3389/fpubh.2023.1304572.


Association of postoperative delirium with serum and cerebrospinal fluid proteomic profiles: a prospective cohort study in older hip fracture patients.

Lozano-Vicario L, Munoz-Vazquez A, Ramirez-Velez R, Galbete-Jimenez A, Fernandez-Irigoyen J, Santamaria E Geroscience. 2024; 46(3):3235-3247.

PMID: 38236313 PMC: 11009174. DOI: 10.1007/s11357-024-01071-w.


References
1.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A . Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. PMC: 7136855. DOI: 10.1001/jama.2020.5394. View

2.
Ritchie C, Molinuevo J, Truyen L, Satlin A, Van der Geyten S, Lovestone S . Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project. Lancet Psychiatry. 2015; 3(2):179-86. DOI: 10.1016/S2215-0366(15)00454-X. View

3.
Griffith G, Morris T, Tudball M, Herbert A, Mancano G, Pike L . Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020; 11(1):5749. PMC: 7665028. DOI: 10.1038/s41467-020-19478-2. View

4.
Battle A, Brown C, Engelhardt B, Montgomery S . Genetic effects on gene expression across human tissues. Nature. 2017; 550(7675):204-213. PMC: 5776756. DOI: 10.1038/nature24277. View

5.
Niedzwiedz C, ODonnell C, Jani B, Demou E, Ho F, Celis-Morales C . Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020; 18(1):160. PMC: 7255908. DOI: 10.1186/s12916-020-01640-8. View